 |
인쇄하기
취소
|
Ildong to join hands with Taiwan Liposome Company
Ildong Pharmaceutical plans to commercialize ProFlow Injection (prostaglandin E1) in Korea through an exclusive distribution with Taiwan based Taiwan Liposome Company (TLC).
Ildong forecasts that TLC’s ProFlow will take 30 percent of the domestic PGE1 Injection market valued at 15 billion won.
Prostaglandin E1 (PGE1) is pharmaceutically known as Alprostadil. It is used as a drug in the tr...
Ildong forecasts that TLC’s ProFlow will take 30 percent of the domestic PGE1 Injection market valued at 15 billion won.
Prostaglandin E1 (PGE1) is pharmaceutically known as Alprostadil. It is used as a drug in the tr...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.